125 related articles for article (PubMed ID: 15485541)
1. Skin hyperpigmentation induced by olanzapine, a novel antipsychotic agent.
Jhirwal OP; Parsad D; Basu D
Int J Dermatol; 2004 Oct; 43(10):778-9. PubMed ID: 15485541
[No Abstract] [Full Text] [Related]
2. Dorsal hand skin hyperpigmentation following oral olanzapine (Zyprexa) use.
Cary JH; Li BS; Maibach HI
Contact Dermatitis; 2018 Oct; 79(4):254-255. PubMed ID: 30079483
[No Abstract] [Full Text] [Related]
3. Doxycycline-induced photo-onycholysis.
Carroll LA; Laumann AE
J Drugs Dermatol; 2003 Dec; 2(6):662-3. PubMed ID: 14711147
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine-Induced Reversible Pellagroid Skin Lesion.
Singh LK; Sahu M; Praharaj SK
Curr Drug Saf; 2015; 10(3):251-3. PubMed ID: 26077832
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.
Tavares-Bello R
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1434-5. PubMed ID: 17958867
[No Abstract] [Full Text] [Related]
6. Unilateral Digital Hyperpigmentation in a Teenager.
Campos Muñoz L; Fueyo Casado A; López Bran E
Actas Dermosifiliogr; 2017 Dec; 108(10):943-944. PubMed ID: 28802486
[No Abstract] [Full Text] [Related]
7. Olanzapine-induced oculogyric crisis in a patient with schizophrenia.
Chakraborty R; Chatterjee A; Chaudhury S
Indian J Med Sci; 2008 Jun; 62(6):238-9. PubMed ID: 18603742
[No Abstract] [Full Text] [Related]
8. Weight loss during therapy with olanzapine orally disintegrating tablets: two case reports.
Kozumplik O; Uzun S; Jakovljević M
Psychiatr Danub; 2009 Mar; 21(1):72-4. PubMed ID: 19270625
[TBL] [Abstract][Full Text] [Related]
9. Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain.
Karagianis J; Hoffmann VP; Arranz B; Treuer T; Maguire GA; de Haan L; Chawla B
Hum Psychopharmacol; 2008 Jun; 23(4):275-81. PubMed ID: 18338426
[TBL] [Abstract][Full Text] [Related]
10. Hyperpigmentation mimicking Laugier syndrome, levodopa therapy and Addison's disease.
Vega Gutiérrez J; Miranda Romero A; Martínez G; Torrero MV; López de Juan M
J Eur Acad Dermatol Venereol; 2003 May; 17(3):324-7. PubMed ID: 12702077
[TBL] [Abstract][Full Text] [Related]
11. Skin rash occurring with olanzapine pamoate, but not with oral olanzapine, in a male with juvenile idiopathic arthritis.
Solfanelli A; Curto M; Dimitri-Valente G; Kotzalidis GD; Gasperoni C; Sani G; Manfredi G; Rapinesi C; Comparelli A; Girardi P
J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):232-4. PubMed ID: 23607414
[No Abstract] [Full Text] [Related]
12. [Post-injection syndrome and olanzapine pamoate: A severe case report].
Descusse A; Chebili S; Artiges E
Encephale; 2017 Aug; 43(4):405. PubMed ID: 27349579
[No Abstract] [Full Text] [Related]
13. [Akathisia in the course of olanzapine treatment].
Makkos Z; Csonka A
Neuropsychopharmacol Hung; 2006 Dec; 8(4):215-7. PubMed ID: 17211056
[TBL] [Abstract][Full Text] [Related]
14. Relationship between smoking and psychotic symptoms in a patient treated with oral olanzapine. A case report.
Leal-Micharet A; Vaz-Leal FJ; Méndez-Salguero MJ; Méndez-Sánchez F; Baltasar-Tello I; Gómez-Tovar B; Gajardo-Galán V
Actas Esp Psiquiatr; 2014; 42(5):263-6. PubMed ID: 25179099
[No Abstract] [Full Text] [Related]
15. Hyperpigmented hand lesion - A woodland's souvenir.
Loyal J; Pierson JC
Eur J Intern Med; 2016 Dec; 36():e7-e8. PubMed ID: 27542976
[No Abstract] [Full Text] [Related]
16. Mucocutaneous lesions and nail pigmentation in a patient with essential thrombocytosis.
Calleja Algarra A; Miguel RA; Tous Romero F; Maroñas Jiménez L
Aust Fam Physician; 2017; 46(4):222-224. PubMed ID: 28376576
[No Abstract] [Full Text] [Related]
17. Acral pigmentation in alkaptonuria resembling degenerative collagenous plaques of the hands: a report of five cases.
Thomas M; Jebaraj JI; Thomas M; George R
J Am Acad Dermatol; 2011 Aug; 65(2):e45-e46. PubMed ID: 21763547
[No Abstract] [Full Text] [Related]
18. Considerations regarding the use of metformin with olanzapine.
Alamiri B
Am J Psychiatry; 2008 Sep; 165(9):1205-6; author reply 1207. PubMed ID: 18765498
[No Abstract] [Full Text] [Related]
19. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
István S; Agoston T; Tamás T; Zoltán J
Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
[TBL] [Abstract][Full Text] [Related]
20. [Subjective and objective evaluation of olanzapine treatment in schizophrenia].
Jarema M; Murawiec S; Tafliński T
Psychiatr Pol; 2004; 38(5):895-909. PubMed ID: 15523935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
